Literature DB >> 9607728

Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas.

C Scurini1, L Quadro, O Fattoruso, U Verga, A Libroia, G Lupoli, E Cascone, L Marzano, S Paracchi, B Busnardo, M E Girelli, A Bellastella, V Colantuoni.   

Abstract

Medullary thyroid carcinomas (MTC) occur sporadically or as part of inherited multiple endocrine neoplasia (MEN) type 2 syndromes. To recognize misdiagnosed familial cases and to establish the frequency of somatic mutations, a series of 50 patients, clinically diagnosed with sporadic MTC, were analyzed for mutations in the RET proto-oncogene. The clinical management of the patient and of the family is different in the two cases. Germline mutations were detected in three independent cases, demonstrating that they were associated to familial MTC. The mutations affected exon 11 in two cases and exon 14 in one case. Somatic mutations were detected in eight patients (30%) and they were indicative of sporadic MTC. In seven cases the mutation affected codon 918 of exon 16 and in one case codon 634 in exon 11. No RET mutations were detected in the remaining patients. A different genetic and clinical management is proposed for individuals with a diagnosis of familial or sporadic MTC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9607728     DOI: 10.1016/s0303-7207(97)00234-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

2.  Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.

Authors:  Isabel Peixoto Callejo; José Américo Brito; Carlos Manuel Zagalo; Jorge Rosa Santos
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

3.  Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up.

Authors:  Beatriz González-Yebra; Raúl Peralta; Ana Lilia González; Marco Antonio Ayala-Garcia; María E Medrano Ortiz de Zarate; Mauricio Salcedo
Journal:  Diagn Pathol       Date:  2012-06-07       Impact factor: 2.644

Review 4.  RET and neuroendocrine tumors.

Authors:  Yoshiki Murakumo; Mayumi Jijiwa; Naoya Asai; Masatoshi Ichihara; Masahide Takahashi
Journal:  Pituitary       Date:  2006       Impact factor: 3.599

5.  Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.

Authors:  Sara Sheikholeslami; Marjan Zarif Yeganeh; Laleh Hoghooghi Rad; Hoda Golab Ghadaksaz; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2014-02       Impact factor: 1.429

6.  Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation.

Authors:  A Miyauchi; H Futami; N Hai; T Yokozawa; K Kuma; N Aoki; S Kosugi; K Sugano; K Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1999-01

7.  Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET Mutation

Authors:  Samira Ehyaei; Mehdi Hedayati; Marjan Zarif-Yeganeh; Sara Sheikholeslami; Mahsa Ahadi; Sayed Asadollah Amini
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

8.  Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.

Authors:  M M Moura; B M Cavaco; A E Pinto; R Domingues; J R Santos; M O Cid; M J Bugalho; V Leite
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

9.  Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.

Authors:  Jes Sloth Mathiesen; Jens Peter Kroustrup; Peter Vestergaard; Kirstine Stochholm; Per Løgstrup Poulsen; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Sten Schytte; Stefano Christian Londero; Henrik Baymler Pedersen; Christoffer Holst Hahn; Bjarki Ditlev Djurhuus; Jens Bentzen; Sören Möller; Mette Gaustadnes; Maria Rossing; Finn Cilius Nielsen; Kim Brixen; Anja Lisbeth Frederiksen; Christian Godballe
Journal:  Endocr Connect       Date:  2018-05-14       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.